✦ LIBER ✦

Benefit-Risk Assessment of Drotrecogin Alfa (Activated) in the Treatment of Sepsis

✍ Scribed by Dr Daniel De Backer

Book ID: 119925784
Publisher: Springer International Publishing AG
Year: 2007
Tongue: English
Weight: 155 KB
Volume: 30
Category: Article
ISSN: 0114-5916
DOI: 10.2165/00002018-200730110-00002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Drotrecogin alfa (activated) in the trea

Drotrecogin alfa (activated) in the treatment of severe sepsis

✍ Vincent, Jean-Louis 📂 Article 📅 2006 🏛 Expert Reviews 🌐 English ⚖ 445 KB

Benefit/risk profile of drotrecogin alfa

Benefit/risk profile of drotrecogin alfa (activated) in surgical patients with severe sepsis

✍ Philip S. Barie; Mark D. Williams; Jill Shwed McCollam; Becky M. Bates; Rebecca 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Timing of drotrecogin alfa (activated) t

Timing of drotrecogin alfa (activated) treatment in severe sepsis

✍ Goda Choi,Anne-Cornélie JM de Pont,Marcus J Schultz 📂 Article 📅 2006 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 31 KB

Safety assessment of drotrecogin alfa (a

Safety assessment of drotrecogin alfa (activated) in the treatment of adult patients with severe sepsis

✍ Bernard, Gordon R. (author);Macias, William L. (author);Joyce, David E. (author) 📂 Article 📅 2003 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 76 KB

Safety assessment of drotrecogin alfa (a

Safety assessment of drotrecogin alfa (activated) in the treatment of adult patients with severe sepsis

✍ Bernard, Gordon R. (author);Macias, William L. (author);Joyce, David E. (author) 📂 Article 📅 2003 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 76 KB

Cost-effectiveness of drotrecogin alfa (

Cost-effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in Germany

✍ Aileen R Neilson; Hilmar Burchardi; Chris Chinn; Johannes Clouth; Heinz Schneide 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 116 KB